Clear Labs, which has developed a next-generation sequencing platform for turnkey diagnostics, raised a $30 million Series D, CEO Sasan Amini told Axios exclusively.
Why it matters: The funds will fuel international expansion, which can improve the product's accuracy while increasing lab efficiency.
